Your shopping cart is currently empty

K1586 is an effective guanidine derivative targeting Chk1. It enhances the degradation of Chk1, sensitizing colorectal cancer cells to ionizing radiation, and demonstrates anticancer activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | K1586 is an effective guanidine derivative targeting Chk1. It enhances the degradation of Chk1, sensitizing colorectal cancer cells to ionizing radiation, and demonstrates anticancer activity. |
| In vitro | K1586 reduces cell proliferation in a dose-dependent manner when applied at concentrations of 0.001-100 μM over 72 hours. At concentrations of 10-20 μM for 24 hours, it increases the relative length of the S phase and significantly extends the duration of the G2/M phase. Additionally, K1586 decreases Chk1 protein levels in a time-dependent manner at 10 μM over a 12-hour period. |
| Formula | C18H18ClN3OS |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.